Arizona State Retirement System’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,764
Closed -$691K 2181
2023
Q4
$691K Sell
11,764
-2,726
-19% -$153K 0.01% 1270
2023
Q3
$631K Buy
14,490
+3,068
+27% +$110K 0.01% 1247
2023
Q2
$413K Sell
11,422
-258
-2% -$10.6K ﹤0.01% 1530
2023
Q1
$434K Buy
11,680
+696
+6% +$31.3K ﹤0.01% 1492
2022
Q4
$498K Buy
10,984
+421
+4% +$27.2K ﹤0.01% 1384
2022
Q3
$738K Buy
10,563
+37
+0.4% +$2.74K 0.01% 1096
2022
Q2
$707K Buy
10,526
+78
+0.7% +$4.96K 0.01% 1168
2022
Q1
$859K Buy
10,448
+722
+7% +$73.8K 0.01% 1156
2021
Q4
$1.43M Sell
9,726
-82
-0.8% -$12.7K 0.01% 893
2021
Q3
$1.74M Buy
9,808
+173
+2% +$27.8K 0.01% 785
2021
Q2
$1.56M Sell
9,635
-611
-6% -$98.1K 0.01% 865
2021
Q1
$1.75M Buy
10,246
+1,850
+22% +$366K 0.02% 799
2020
Q4
$1.84M Sell
8,396
-163
-2% -$35.2K 0.02% 724
2020
Q3
$1.42M Buy
8,559
+2,180
+34% +$298K 0.01% 755
2020
Q2
$728K Buy
6,379
+361
+6% +$35K 0.01% 926
2020
Q1
$463K Buy
+6,018
New +$540K 0.01% 1039

Other funds holding MRTX

Arizona State Retirement System's MRTX Position: Q1 2024 in Review

Arizona State Retirement System sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 11,764 shares — an estimated $691K sold.

Arizona State Retirement System first reported a position in MRTX in Q1 2020 and held it in 16 quarters. The position peaked at $1.84M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Arizona State Retirement System reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 11,764 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $691K.
  • Arizona State Retirement System first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Arizona State Retirement System's Mirati Therapeutics, Inc. Common Stock position peaked at $1.84M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Arizona State Retirement System's 13F filing for Q1 2024, filed 7 May 2024.